Apply
Recommend someone

Senior AI/Data Scientist

Novai Ltd

£60,000 - £75,000
Full-time

Reading, United Kingdom

Hybrid

Recommend someone
Apply
Benefits & perks

Benefits:

· Competitive salary

· Share option scheme

· Company pension

· Great office space

· Health and Dental care

· Perkbox

· Online training courses - Coursera

About the role

Company Description

Novai is a UK-based growing biotechnology start-up, commercialising an exciting and cutting-edge discovery in drug development. Our product is a novel diagnostic platform, combining a retinal biomarker with an AI algorithm to identify cellular level disease activity for the first time in humans. Our pioneering technology predicts disease progression and measures the impact of current and future therapeutics in glaucoma and Age-related Macular Degeneration (AMD). Following the analysis of Phase II clinical research results, we believe our product may also be successful in identifying a number of neurodegenerative diseases including; Alzheimer’s, Parkinson’s Disease and Multiple Sclerosis.

We have exciting positions available for experienced senior AI engineers/data scientists, developing and validating new AI based systems.

Location:

Office in Reading/London/partial remote

Key responsibilities

Role & Responsibilities:

· Lead development of Novai algorithms and software with creativity, initiative and passion

· Assist in the development of the technical capacity of the team, maintain and promote good working practices and a positive culture.

· To provide novel input in terms of high-level ideas and the technical and practical implementation of these.

· To complete hands on and off design and development coding tasks (this is a majority coding role)

· To help evaluate documentation and test technical systems.

· Support the writing up, editing and responding to technical reports – client and internal company

· Work cross functionally with other non-technical members of the company.

· Opportunity to liaise with customers

· Maintain up-to-date knowledge and skillset via conference attendance and training/self-development

· Regular travel to UK conferences and team meetings within UK working hours.

Desired skills, experience and attributes

Essential Skills

· OpenCV or another image analysis library

· Python – 3 years minimum

· Strong understanding of machine learning techniques and frameworks, and their real-world applications

· Experience with Deep learning/CNNs, Keras/TensorFlow/others, SVMs/Random Forests etc.

· Strong general and technical communication – communicate complex concepts to non-technical team members across the company, and to clients

· To be a self-starter and able to develop an initial concept through to validation and publication level data reports.

· Creative and research driven thinker, ability to solve complex problems using scientific methodology

Desirable Skills

· Medical Image Analysis

· SimpleITK

· Linux

· Healthcare domain knowledge

· Cloud computing – AWS, containerisation

· Robust, practical and proven knowledge of statistics

· Use of statistics packages such as SPSS/Prism

Education:

· MSc Computer Science, Maths or Engineering, PhD Ideally

About us

Overview

Novai is a British biotechnology start-up, commercialising DARC Technology, an exploratory retinal biomarker for use in Age-related Macular Degeneration (AMD) & glaucoma clinical studies. DARC combines an innovative patented biologic with a state-of-the-art AI algorithm and uses standard imaging equipment to identify cellular level disease activity.

DARC Technology can be used to measure the impact of current and future therapeutics and interventions by assessment of disease activity whilst identifying non-responders to existing and new interventions, resulting in the avoidance of costly, ineffective or un-required medical management.

DARC helps to stratify patients in clinical trials, resulting in the creation of enriched patient cohorts, consisting of those at highest risk of rapid disease progression.

DARC has been developed by Professor M Francesca Cordeiro at University College London through Wellcome Trust funding and is now approved as an exploratory biomarker by the FDA & MHRA. Following further analysis of Phase II data, several other indications may follow, including Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Diabetes Mellitus and Cancer.

Novai is headquartered in Reading, UK. For more information, please visit our website www.novai.co.uk

Our culture

We Shine a Light – on new possibilities, on new pathways for diagnosing and treating the most complex disease, and on ourselves in what we’re capable of achieving. We open new opportunities for our patients and doctors, lighting the way for future clinical care. We do this internally within the organization, shining a light on challenges and problems we’re facing, and working to solve them with clarity and transparency around our science and technological development.This includes approaching new ideas and data with healthy skepticism and fostering critical thinking, as well as building strong evidence and best practices. 

Accountability Doesn’t Have a Deadline – we show up to achieve results and deliver with consistency. We know that small accountable teams can outpace large teams filled with uncertainty and we work together to build our foundations to be responsible when things work and when they don’t. 

Integrity Isn’t Optional – We believe in high integrity in all areas of life and work. We trust each other and build trust across our network, we support each other across challenges,don’t shy away from mistakes and imperfections.

Resilience is in our DNA – we know the startup journey is bumpy and we’re not afraid of it. We embrace challenges and learn from mistakes. We experiment, adapt and endure.Our strength of character is second to none, we don’t sweat the small things and we strive for positivity. 

Be Aspirational – We are visionaries and pioneers of technology in our field. We dream big, and influence others around us to strive to be great. We want to inspire clinicians about new technological possibilities and inspire patients about the future of their health. We are leaders inside and outside the team, and with our clients and collaborators.We want to develop brilliant services and technology that pushes boundaries in the field. We strive to go beyond challenges,beyond expectations, and for us learning is never done. 

Aggressively Collect Data – We believe in the power and strength of data, and its ability to provide us with insights. We collect data in all areas of the organization and use it as atool for continuous improvement and learning. 

Industry
Biotechnology
Size
1-15
Last investment round
Series A
Recommend someone
Apply